Article
Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Molecular carcinogenesis - 1 Aug 2000
Rauh-Adelmann C, Lau K M, Sabeti N, Long J P, Mok S C, Ho S M
Abstract excerpt
Germline mutations of BRCA1 and BRCA2 predispose to hereditary breast, ovarian, and possibly prostate cancer, yet structural mutations in these genes are infrequent in sporadic cancer cases. To better define the involvement of these genes in sporadic cancers, we characterized expression levels of BRCA1 and BRCA2 transcripts in cancer cell lines derived from neoplasms of the ovary, prostate, and breast and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
